351 related articles for article (PubMed ID: 28543813)
1. Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.
Sabato LA; Salerno DM; Moretz JD; Jennings DL
Pharmacotherapy; 2017 Aug; 37(8):944-955. PubMed ID: 28543813
[TBL] [Abstract][Full Text] [Related]
2. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A
Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary artery pulsatility index predicts prolonged inotrope/pulmonary vasodilator use after implantation of continuous flow left ventricular assist device.
Aggarwal V; Tume SC; Rodriguez M; Adachi I; Cabrera AG; Tunuguntla H; Qureshi AM
Congenit Heart Dis; 2019 Nov; 14(6):1130-1137. PubMed ID: 31802608
[TBL] [Abstract][Full Text] [Related]
5. Inhaled Pulmonary Vasodilators and Thoracic Organ Transplantation: Does Evidence Support Its Use and Cost Benefit?
Krebs R; Morita Y
Semin Cardiothorac Vasc Anesth; 2020 Mar; 24(1):67-73. PubMed ID: 31451092
[TBL] [Abstract][Full Text] [Related]
6. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction.
Theodoraki K; Tsiapras D; Tsourelis L; Zarkalis D; Sfirakis P; Kapetanakis E; Alivizatos P; Antoniou T
Acta Anaesthesiol Scand; 2006 Nov; 50(10):1213-7. PubMed ID: 16978158
[TBL] [Abstract][Full Text] [Related]
7. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
Theodoraki K; Thanopoulos A; Rellia P; Leontiadis E; Zarkalis D; Perreas K; Antoniou T
Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Milrinone After Left Ventricular Assist Device Implantation.
Haglund NA; Burdorf A; Jones T; Shostrom V; Um J; Ryan T; Shillcutt S; Fischer P; Cox ZL; Raichlin E; Anderson DR; Lowes BD; Dumitru I
J Card Fail; 2015 Oct; 21(10):792-7. PubMed ID: 25937146
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Braun S; Schrötter H; Schmeisser A; Strasser RH
Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension.
Argenziano M; Choudhri AF; Moazami N; Rose EA; Smith CR; Levin HR; Smerling AJ; Oz MC
Ann Thorac Surg; 1998 Feb; 65(2):340-5. PubMed ID: 9485226
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation.
Wagner F; Dandel M; Günther G; Loebe M; Schulze-Neick I; Laucke U; Kuhly R; Weng Y; Hetzer R
Circulation; 1997 Nov; 96(9 Suppl):II-291-6. PubMed ID: 9386113
[TBL] [Abstract][Full Text] [Related]
15. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
Olschewski H; Ghofrani HA; Walmrath D; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Intensive Care Med; 1998 Jun; 24(6):631-4. PubMed ID: 9681789
[TBL] [Abstract][Full Text] [Related]
16. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W
Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224
[TBL] [Abstract][Full Text] [Related]
17. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
[TBL] [Abstract][Full Text] [Related]
19. [SPECIFICS OF INHALED ILOPROST PHARMACODYNAMICS IN PATIENTS WITH SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION].
Bautin AE; Iakovlev AS; Tashkhanov DM; Datsenko SV; Marichev AO; Popov MA; Fedotov PA
Anesteziol Reanimatol; 2015; 60(2):4-7. PubMed ID: 26148353
[TBL] [Abstract][Full Text] [Related]
20. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.
Haraldsson s A; Kieler-Jensen N; Ricksten SE
Anesth Analg; 2001 Dec; 93(6):1439-45, table of contents. PubMed ID: 11726420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
